SupplySide Global 2026: Bactolife’s Helm binding proteins block harmful gut compounds

Bactolife CEO Sebastian Søderberg and co-founder and chief scientific officer Dr. Sandra Wingaard Thrane discuss Helm binding proteins, a novel gut health approach. Unlike probiotics, which introduce beneficial bacteria, or...

SupplySide Global 2026: ADM and Morinaga explore microbiome innovations and the future of gut health

At SupplySide Global 2026, ADM’s Divya Mohan, director of Global Food and Beverage Creation, Design and Development, and Health and Wellness, explored the emerging potential of phagebiotics, their role in the microbiome and...

SupplySide Global 2026: Givaudan targets metabolic health with Ayurvedic botanical Novaberin

Givaudan has launched Novaberin, a patent-pending botanical made from standardized extracts of two Ayurvedic botanicals, barberry and amla, at SupplySide Global 2026. Brian Appell, the company’s marketing manager of Nutra &...

CPHI Milan 2026: Natix backs microencapsulated enzymes for digestive and metabolic health

Stefaan Vandaele, CEO of Natix, noted that demand for plant- and animal-derived enzymes is rising, driven by interest in bioactives and the clean label trend — yet functionality remains essential. He highlighted the scientific...

CPHI Milan 2026: Cargill targets children and seniors with better-tasting, low-impurity excipients

Cargill’s Eelco van Oosterbosch, marketing director for Health and Nutrition, and Catherine Boghmans, senior applications specialist, highlighted the overlaps and differences between pharmaceutical ingredients and dietary...

CPHI Milan 2026: Indena champions biology over trends in delivery format choice

Stefano Togni, chief commercial officer at Indena, discussed how the industry is at the intersection of botanical science, delivery formats, and pharmaceutical rigor applied to nutraceuticals. He underscored that the biology of...